Literature DB >> 11979448

Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.

Laura Gil1, Marta Azañedo, Marina Pollán, Eva Cristobal, Begoña Arribas, Luis García-Albert, Alfredo García-Sáiz, María Luisa Maestro, Antonio Torres, Javier Menárguez, José M Rojas.   

Abstract

Multiple endocrine neoplasia type 2A (MEN 2A) is associated with specific germline missense mutations in the RET proto-oncogene. This locus encodes a receptor tyrosine kinase whose activation requires the formation of a multimeric receptor complex including GDNF as a ligand and GFR alpha 1 as a coreceptor. In order to explore the role of RET, GFR alpha 1 and GDNF genes in the variation of phenotypes observed in MEN2A families, we analysed germline mutations of these genes in 4 unrelated Spanish MEN2A families (23 cases studied). We found 2 novel variants corresponding to a single change in position + 47 (intron 12) of RET and position +22 (intron 7) of GFR alpha 1. Furthermore, we observed strong co-segregation between 2 polymorphisms of RET [G691S (exon 11) and S904S (TCC-TCG, exon 15) (100%, Fisher's exact test, p< 0.001)]. More interestingly, we found that these polymorphisms occurred at a significantly high frequency in patients with age at onset < 20 years old (Kruskal-Wallis's and Fisher's exact test, p = 0.007). These findings suggest that the G691S and S904S variants of RET may somehow play a role on the age of onset of MEN 2A. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979448     DOI: 10.1002/ijc.10298

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Authors:  V Neocleous; N Skordis; G Portides; E Efstathiou; C Costi; N Ioannou; M Pantzaris; V Anastasiadou; C Deltas; L A Phylactou
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

2.  Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.

Authors:  Sara Sheikholeslami; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad; Hoda Golab Ghadaksaz; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2014-02       Impact factor: 1.429

3.  The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.

Authors:  Carla Colombo; Emanuela Minna; Maria Grazia Rizzetti; Paola Romeo; Daniele Lecis; Luca Persani; Piera Mondellini; Marco A Pierotti; Angela Greco; Laura Fugazzola; Maria Grazia Borrello
Journal:  Orphanet J Rare Dis       Date:  2015-03-01       Impact factor: 4.123

4.  Association of medullary sponge kidney and hyperparathyroidism with RET G691S/S904S polymorphism: a case report.

Authors:  Muhammad Usman Janjua; Xiao-Dan Long; Zhao-Hui Mo; Chang-Sheng Dong; Ping Jin
Journal:  J Med Case Rep       Date:  2018-07-09

5.  A unique RET EXON 11 (G691S) polymorphism in an Indian patient with a collision tumor of the thyroid.

Authors:  Bharat Rekhi; Rakesh R Badhe; Maria Alina Desouza; Devendra Chaukar; Anil K D'Cruz; Suprita Arya; S V Kane
Journal:  Diagn Pathol       Date:  2007-10-16       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.